Reduced numbers and proapoptotic features of mucosal-associated invariant T cells as a characteristic finding in patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 21, Issue 7, 2015, Pages 1529-1540

  Hiejima, Eitaro ^a   Kawai, Tomoki ^a   Nakase, Hiroshi ^a   Tsuruyama, Tatsuaki ^a   Morimoto, Takeshi ^b   Yasumi, Takahiro ^a   Taga, Takashi ^c   Kanegane, Hirokazu ^d,e   Hori, Masayuki ^a   Ohmori, Katsuyuki ^f   Higuchi, Takeshi ^f   Matsuura, Minoru ^a   Yoshino, Takuya ^a   Ikeuchi, Hiroki ^b   Kawada, Kenji ^a   Sakai, Yoshiharu ^a   Kitazume, Mina T ^g   Hisamatsu, Tadakazu ^g   Chiba, Tsutomu ^a   Nishikomori, Ryuta ^a   Heike, Toshio ^a   more..

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

^d SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f KYOTO UNIVERSITY HOSPITAL   (Japan)

^g KEIO UNIVERSITY   (Japan)

Author keywords

human; inflammatory bowel disease; mucosal associated invariant T cells

Indexed keywords

CASPASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 22; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; APOPTOSIS; ARTICLE; BLOOD ANALYSIS; COLON MUCOSA; CROHN DISEASE; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASE; INTESTINE MUCOSA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUCOSAL ASSOCIATED INVARIANT T CELL; MUCOSAL IMMUNITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE MUCOSA; T LYMPHOCYTE; ULCERATIVE COLITIS; AGED; DENDRITIC CELL; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; APOPTOSIS; CYTOKINES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, INNATE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; T-LYMPHOCYTES;

EID: 84932092385     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000397     Document Type: Article

References (40)

1. Sakuraba A, Sato T, Kamada N, et al. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology. 2009;137:1736-1745.
2. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1756-1767.
3. Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129:550-564.
4. Fuss IJ, Heller F, Boirivant M, et al. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest. 2004;113:1490-1497.
5. Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol. 2011;11:131-142.
6. Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol. 2010;11:197-206.
7. Godfrey DI, Rossjohn J, McCluskey J. Fighting infection with your MAITs. Nat Immunol. 2010;11:693-695.
8. Treiner E, Duban L, Bahram S, et al. Selection of evolutionarily conserved mucosal-Associated invariant T cells by MR1. Nature. 2003;422:164-169.
9. Martin E, Treiner E, Duban L, et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol. 2009;7:e54.
10. Dusseaux M, Martin E, Serriari N, et al. Human MAIT cells are xenobiotic-resistant, tissue-Targeted, CD161hi IL-17-secreting T cells. Blood. 2011;117:1250-1259.
11. Kjer-Nielsen L, Patel O, Corbett AJ, et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature. 2012;491:717-723.
12. Gerart S, Siberil S, Martin E, et al. Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP. Blood. 2013;121:614-623.
13. Pachlopnik Schmid J, Canioni D, Moshous D, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood. 2011;117:1522-1529.
14. Yang X, Kanegane H, Nishida N, et al. Clinical and genetic characteristics of XIAP deficiency in Japan. J Clin Immunol. 2012;32:411-420.
15. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
16. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1:514.
17. Rachmilewitz D. Coated mesalazine (5-Aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298:82-86.
18. Chinen H, Matsuoka K, Sato T, et al. Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells. Gastroenterology. 2007;133:559-573.
19. Broadhurst MJ, Leung JM, Kashyap V, et al. IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med. 2010;2:60ra88.
20. Le Bourhis L, Martin E, Peguillet I, et al. Antimicrobial activity of mucosal-Associated invariant T cells. Nat Immunol. 2010;11:701-708.
21. Walker LJ, Kang YH, Smith MO, et al. Human MAIT and CD8alphaalpha cells develop from a pool of type-17 precommitted CD8+ T cells. Blood. 2012;119:422-433.
22. Miyazaki Y, Miyake S, Chiba A, et al. Mucosal-Associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol. 2011; 23:529-535.
23. Serriari NE, Eoche M, Lamotte L, et al. Innate mucosal-Associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol. 2014;176:266-274.
24. Mora JR, Von Andrian UH. Specificity and plasticity of memory lymphocyte migration. Curr Top Microbiol Immunol. 2006;308:83-116.
25. Souza HS, Elia CC, Spencer J, et al. Expression of lymphocyteendothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut. 1999;45:856-863.
26. Meenan J, Spaans J, Grool TA, et al. Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. Gut. 1997;40:241-246.
27. Kempster SL, Kaser A. alpha4beta7 integrin: beyond T cell trafficking. Gut. 2014;63:1377-1379.
28. Cosgrove C, Ussher JE, Rauch A, et al. Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood. 2013;121:951-961.
29. Jager S, Stange EF, Wehkamp J. Inflammatory bowel disease: an impaired barrier disease. Langenbecks Arch Surg. 2013;398:1-12.
30. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis as a prerequisite for IBD. Gut. 2004;53:1057.
31. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53:1-4.
32. Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev. 2013;26:2-18.
33. Gardiner KR, Halliday MI, Barclay GR, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut. 1995;36:897-901.
34. Deveraux QL, Takahashi R, Salvesen GS, et al. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997;388:300-304.
35. Eckelman BP, Salvesen GS, Scott FL. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 2006; 7:988-994.
36. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-317.
37. Filipovich AH, Zhang K, Snow AL, et al. X-linked lymphoproliferative syndromes: brothers or distant cousins?. Blood. 2010;116:3398-3408.
38. Abrahamsson SV, Angelini DF, Dubinsky AN, et al. Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-Associated invariant T cells in multiple sclerosis. Brain. 2013;136:2888-2903.
39. Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008;29:947-957.
40. Sugimoto K, Ogawa A, Mizoguchi E, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008; 118:534-544.